DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Showing posts with label 1-((3-Methoxyphenyl)sulfonyl)piperidine: Piperidine. Show all posts
Showing posts with label 1-((3-Methoxyphenyl)sulfonyl)piperidine: Piperidine. Show all posts

Saturday 6 September 2014

1-((3-Methoxyphenyl)sulfonyl)piperidine: Piperidine, 1-[(3-methoxyphenyl)sulfonyl]-

Reaction scheme

compd 1
3-Methoxy-N-morpholinobenzenesulfonamide: Benzenesulfonamide, 3-methoxy-N-4-morpholinyl-; (1) (1255365-27-5)

1H NMR pdf(400 MHz, CDCl3, 7.27 ppm) δ: 2.64 (t, J = 4.8 Hz, 4 H (NCH2CH2O)2), 3.62 (t, J = 4.8 Hz, 4 H, (NCH2CH2O)2), 3.87 (s, 3 H, OMe), 5.60 (s, 1 H, NH), 7.14 (dd, = 8.0, 2.0 Hz, 1 H, Ar-H), 7.43 (t, = 8.0 Hz, 1 H, Ar-H), 7.49 (t, J = 2.0 Hz, 1 H, Ar-H), 7.57 (d,J = 8.0 Hz, 1 H, Ar-H); 13C NMR pdf(100 MHz, CDCl3, 77.0 ppm) δ: 55.6, 56.4, 66.5, 112.5, 119.4, 120.1, 129.8, 139.7, 159.6; IR n max (film)/cm-1 3212, 2963, 2856, 1597, 1478, 1433, 1361, 1317, 1287, 1242, 1157, 1109, 1034, 864, 685 (principal peaks); HRMS (FTMS+ p-NSI) found m/z 295.0721 [M+Na]+, C11H16N2O4SNa requires m/z 295.0723. Reverse phase HPLC analysis reveals purity >99% (run on an Agilent Zorbax SB-C18, 5 µm, 4.6 x 150 mm column (23 °C) at a flow rate of 1.5 mL/min of 70:30 MeCN:H2O observed at 210 nm giving a retention time of 1.32 min, 1.0 mg/mL in CH3CN).


compd 2

1-((3-Methoxyphenyl)sulfonyl)piperidine: Piperidine, 1-[(3-methoxyphenyl)sulfonyl]-; (2) (173681-65-7)
mp 115-116 °C;


 1H NMR pdf(400 MHz, DMSO-d6, 2.50 ppm) 
δ: 1.30-1.35 (m, 2 H, N(CH2CH2)2CH2), 
1.47-1.52 (m, 4 H, N(CH2CH2)2CH2),
2.85 (t, J = 5.2 Hz, 4 H, N(CH2CH2)2CH2), 
3.83 (s, 3 H, OMe), 
7.16 (t, J = 2.1 Hz, 1 H, Ar-H), 
7.25-7.30 (m, 2 H, Ar-H), 
7.55 (t, J = 8.0 Hz, 1 H, Ar-H);





 13C NMRpdf(100 MHz, DMSO-d6, 39.5 ppm) δ: 22.8, 24.7, 46.6, 55.6, 112.3, 118.7, 119.5, 130.5, 136.7, 159.5; 


IR nmax(film)/cm-1 2940, 2851, 1597, 1478, 1359, 1340, 1318, 1287, 1241, 1167, 1098, 1040, 931, 856, 724, 688; (principal peaks); 


HRMS (FTMS+p-NSF) found m/z 256.1002 [M+H]+, C12H18 NO3S requires m/z 256.1002. 

Reverse phase HPLC analysis reveals purity >99% (run on an Agilent Zorbax SB-C18, 5 µm, 4.6 x 150 mm column (23 °C) at a flow rate of 1.5 mL/min of 75:25 MeCN:H2O observed at 210 nm giving a retention time of 1.95 min, 1.0 mg/mL in MeCN).




img